$LAZR
Luminar Technologies, Inc./DE

2020 Q3 Form 10-Q Financial Statement

#000156459020051947 Filed on November 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $4.223M $5.800M
YoY Change
Cost Of Revenue $6.924M $7.310M
YoY Change
Gross Profit -$2.701M -$1.510M
YoY Change
Gross Profit Margin -63.96% -26.03%
Selling, General & Admin $8.943M $6.540M
YoY Change
% of Gross Profit
Research & Development $10.15M $9.600M
YoY Change
% of Gross Profit
Depreciation & Amortization $688.0K $610.0K $1.710M
YoY Change -59.77%
% of Gross Profit
Operating Expenses $19.10M $16.14M
YoY Change
Operating Profit -$21.80M -$17.65M -$200.8K
YoY Change 10754.8%
Interest Expense $1.076M -$230.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$9.415M -$60.00K
YoY Change
Pretax Income -$31.21M -$17.94M $1.912M
YoY Change -1732.28%
Income Tax $0.00 $405.3K
% Of Pretax Income 21.2%
Net Earnings -$31.21M -$17.94M $1.507M
YoY Change -2171.32%
Net Earnings / Revenue -739.07% -309.31%
Basic Earnings Per Share -$0.29
Diluted Earnings Per Share -$0.29 -$55.38K
COMMON SHARES
Basic Shares Outstanding 130.6M shares
Diluted Shares Outstanding 130.6M shares

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $167.8M $33.74M
YoY Change
Cash & Equivalents $518.9K $27.08M $1.450M
Short-Term Investments $117.1M $6.659M
Other Short-Term Assets $10.00M
YoY Change
Inventory $2.921M $4.002M
Prepaid Expenses $59.46K $136.4K $193.4K
Receivables $1.000M $1.677M
Other Receivables $0.00 $329.0K
Total Short-Term Assets $578.3K $41.47M $1.644M
YoY Change -64.81% 8365.0%
LONG-TERM ASSETS
Property, Plant & Equipment $7.800M $7.867M
YoY Change
Goodwill $701.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.300M $1.829M
YoY Change
Total Long-Term Assets $190.9M $10.40M $404.7M
YoY Change -52.84%
TOTAL ASSETS
Total Short-Term Assets $578.3K $41.47M $1.644M
Total Long-Term Assets $190.9M $10.40M $404.7M
Total Assets $191.5M $51.86M $406.4M
YoY Change -52.89% 10487.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.300M $3.456M
YoY Change
Accrued Expenses $2.936M $3.526M $41.36K
YoY Change 6998.05% 951.23%
Deferred Revenue $225.0K
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.900M $7.791M
YoY Change
Total Short-Term Liabilities $3.099M $14.77M $689.3K
YoY Change 349.56% 2934.41%
LONG-TERM LIABILITIES
Long-Term Debt $26.90M $1.555M
YoY Change
Other Long-Term Liabilities $16.70M $1.401M
YoY Change
Total Long-Term Liabilities $43.60M $2.956M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.099M $14.77M $689.3K
Total Long-Term Liabilities $43.60M $2.956M
Total Liabilities $17.10M $18.85M $14.98M
YoY Change 14.12% 3772.04%
SHAREHOLDERS EQUITY
Retained Earnings $2.045M -$222.2M $4.240M
YoY Change -51.77% 1010602.75%
Common Stock $2.954M $24.01K $759.2K
YoY Change 289.1% 0.35%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares 4.958M shares
Shareholders Equity -$279.2M -$211.7M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $406.3M $51.86M $406.4M
YoY Change -0.02% 10487.43%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income -$31.21M -$17.94M $1.507M
YoY Change -2171.32%
Depreciation, Depletion And Amortization $688.0K $610.0K $1.710M
YoY Change -59.77%
Cash From Operating Activities -$13.75M -$14.80M -$45.40M
YoY Change -69.71%
INVESTING ACTIVITIES
Capital Expenditures -$1.272M -$370.0K -$1.120M
YoY Change 13.57%
Acquisitions
YoY Change
Other Investing Activities -$110.8M -$6.660M $370.0K
YoY Change -30033.78%
Cash From Investing Activities -$112.0M -$7.030M -$750.0K
YoY Change 14836.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 155.8M -2.630M 88.09M
YoY Change 76.91%
NET CHANGE
Cash From Operating Activities -13.75M -14.80M -45.40M
Cash From Investing Activities -112.0M -7.030M -750.0K
Cash From Financing Activities 155.8M -2.630M 88.09M
Net Change In Cash 30.06M -24.46M 41.94M
YoY Change -28.33%
FREE CASH FLOW
Cash From Operating Activities -$13.75M -$14.80M -$45.40M
Capital Expenditures -$1.272M -$370.0K -$1.120M
Free Cash Flow -$12.48M -$14.43M -$44.28M
YoY Change -71.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
gmhi Threshold Number Of Period To Seek Shareholders Approval Prior To Consummation Of Business Combination To Redeem Their Shares
ThresholdNumberOfPeriodToSeekShareholdersApprovalPriorToConsummationOfBusinessCombinationToRedeemTheirShares
P2D
gmhi Threshold Number Of Period To Provide Opportunity To Shareholders To Sell Their Shares Prior To Consummation Of Business Combination
ThresholdNumberOfPeriodToProvideOpportunityToShareholdersToSellTheirSharesPriorToConsummationOfBusinessCombination
P2D
CY2020Q3 us-gaap Assets
Assets
406303529
CY2020Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
26672
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4072986
gmhi Period Of Maturity Of Trust Account Investments Maximum
PeriodOfMaturityOfTrustAccountInvestmentsMaximum
P180D
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38420462
CY2020Q3 gmhi Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
4049658
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
59460
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
136399
CY2020Q3 us-gaap Assets Current
AssetsCurrent
578334
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1501639
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2353
CY2019Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38713476
CY2020Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
50000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4099658
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-46571
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4026415
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2935896
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3098900
CY2020Q3 gmhi Deferred Underwriting Compensation Liability Noncurrent
DeferredUnderwritingCompensationLiabilityNoncurrent
14000000
CY2020Q3 us-gaap Liabilities
Liabilities
17098900
CY2020Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
384204620
CY2020Q3 gmhi Accrual For State Franchise Taxes Current
AccrualForStateFranchiseTaxesCurrent
30000
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
133004
CY2019Q4 gmhi Accrual For State Franchise Taxes Current
AccrualForStateFranchiseTaxesCurrent
200000
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1102662
dei Document Transition Report
DocumentTransitionReport
false
dei City Area Code
CityAreaCode
310
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
518874
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 us-gaap Assets
Assets
407938951
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1355865
CY2019Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
406434959
dei Local Phone Number
LocalPhoneNumber
209-3010
CY2019Q4 gmhi Deferred Underwriting Compensation Liability Noncurrent
DeferredUnderwritingCompensationLiabilityNoncurrent
14000000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1365240
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
53203
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5000009
CY2019Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38713476
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
24006
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5423191
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5448326
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
407938951
CY2019Q3 gmhi Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
150796
gmhi Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
4408626
gmhi Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
460780
CY2019Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
50000
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
150000
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
150000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-200796
us-gaap Operating Income Loss
OperatingIncomeLoss
-4558626
us-gaap Operating Income Loss
OperatingIncomeLoss
-610780
CY2019Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2112905
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1351950
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
6005266
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1912109
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3206676
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5394486
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
405292
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
171781
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1132843
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1506817
us-gaap Net Income Loss
NetIncomeLoss
-3378457
us-gaap Net Income Loss
NetIncomeLoss
4261643
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2954117
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2044734
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
406303529
CY2020Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 gmhi Reclassifications Of Permanent To Temporary Equity
ReclassificationsOfPermanentToTemporaryEquity
1506820
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5000003
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5000006
CY2019Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38639955
CY2019Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1506817
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
865105
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
3015
gmhi Adjustments To Additional Paid In Capital Underwriters Discounts
AdjustmentsToAdditionalPaidInCapitalUnderwritersDiscounts
8000000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
400000000
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6666666
gmhi Sale Of Warrants Price Per Warrant
SaleOfWarrantsPricePerWarrant
1.50
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10000000
CY2020Q3 gmhi Reclassifications Of Permanent To Temporary Equity
ReclassificationsOfPermanentToTemporaryEquity
-2930140
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4026415
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5000009
gmhi Adjustments To Additional Paid In Capital Stock Issued Deferred Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedDeferredIssuanceCosts
14000000
CY2019Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38639955
CY2019Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
gmhi Reclassifications Of Permanent To Temporary Equity
ReclassificationsOfPermanentToTemporaryEquity
386399550
us-gaap Net Income Loss
NetIncomeLoss
4261643
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5000003
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
6096284
CY2020Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38420462
CY2020Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5448326
CY2020Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38420462
CY2020Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
gmhi Reclassifications Of Permanent To Temporary Equity
ReclassificationsOfPermanentToTemporaryEquity
-2930140
us-gaap Net Income Loss
NetIncomeLoss
-3378457
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5000009
us-gaap Profit Loss
ProfitLoss
-3378457
us-gaap Profit Loss
ProfitLoss
4261643
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-170000
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
148569
gmhi Increase Decrease In Prepaid Expense And Deferred Costs
IncreaseDecreaseInPrepaidExpenseAndDeferredCosts
-76939
gmhi Increase Decrease In Prepaid Expense And Deferred Costs
IncreaseDecreaseInPrepaidExpenseAndDeferredCosts
193429
gmhi Increase Decrease In Deferred Offering Costs Associated With Proposed Public Offering
IncreaseDecreaseInDeferredOfferingCostsAssociatedWithProposedPublicOffering
437375
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2882693
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-294056
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-969658
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
497951
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2353
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-293594
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1556130
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5151647
gmhi Payments To Cash Deposited In Trust Account
PaymentsToCashDepositedInTrustAccount
400000000
gmhi Payments For Proceeds From Interest Reinvested In Trust Account
PaymentsForProceedsFromInterestReinvestedInTrustAccount
-709764
gmhi Payments For Proceeds From Interest Reinvested In Trust Account
PaymentsForProceedsFromInterestReinvestedInTrustAccount
4738939
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
709764
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-404738939
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
400000000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
10000000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
150000
gmhi Payment Of Underwriting Discounts And Commissions
PaymentOfUnderwritingDiscountsAndCommissions
8000000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
865105
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
400984895
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-846366
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1397603
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1365240
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
52489
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
518874
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1450092
gmhi Deferred Underwriting Compensation
DeferredUnderwritingCompensation
14000000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1459136
us-gaap Income Taxes Paid
IncomeTaxesPaid
342729
us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.       Organization and Business Operations</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Organization and General</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gores Metropoulos, Inc. (the “Company”) was incorporated in Delaware on August 28, 2018. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses (the “Business Combination”). The Company has neither engaged in any operations nor generated any revenue to date. The Company’s Sponsor is Gores Metropoulos Sponsor, LLC, a Delaware limited liability company (the “Sponsor”). The Company has selected December 31st as its fiscal year-end.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 20, 2020, the Company formed two new wholly-owned subsidiaries, Dawn Merger Sub I, Inc., a Delaware corporation (“Dawn Merger Sub I”), and Dawn Merger Sub II, LLC (“Dawn Merger Sub II”), a Delaware limited liability company, in contemplation of the Proposed Business Combination (as defined below). </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At September 30, 2020, the Company had not commenced any operations. All activity for the period from August 28, 2018 (inception) through September 30, 2020 relates to the Company’s formation and initial public offering (“Public Offering”) described below, the identification and evaluation of prospective acquisition targets for a Business Combination and the entry into the Merger Agreement (as defined below) in connection with the Proposed Business Combination and transactions contemplated thereby. The Company completed the Public Offering on February 5, 2019 (the “IPO Closing Date”). </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will not generate any operating revenues until after the completion of the Business Combination, at the earliest. Subsequent to the Public Offering, the Company generates non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering and the sale of the Private Placement Warrants (as defined below) held in the Trust Account (as defined below).</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Proposed Luminar Technologies, Inc. Business Combination</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 24, 2020, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, Dawn Merger Sub I, Dawn Merger Sub II and Luminar Technologies, Inc. (“Luminar”), which provides for, among other things: (a) the merger of Dawn Merger Sub I with and into Luminar, with Luminar continuing as the surviving corporation (the “First Merger”); and (b) immediately following the First Merger and as part of the same overall transaction as the First Merger, the merger of Luminar with and into Dawn Merger Sub II, with Dawn Merger Sub II continuing as the surviving entity (the “Second Merger” and, together with the First Merger, the “Mergers”). The transactions set forth in the Merger Agreement, including the Mergers, will constitute a “Business Combination” as contemplated by the Company’s Amended and Restated Certificate of Incorporation. Such transactions are hereinafter referred to as the “Proposed Business Combination.”</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Merger Agreement and the transactions contemplated thereby were unanimously approved by the Board of Directors of the Company (the “Board”) on August 23, 2020.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">The Merger Agreement</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Merger Agreement, the aggregate merger consideration payable to the stockholders of Luminar will be a number of shares of Company class A common stock, par value $0.0001 per share (the “Class A Stock”) and Company Class B common stock, par value $0.001 per share (the “Class B Stock”) (each deemed to have a value of $10.00 per share) with an implied value equal to $2,928,828,692, plus an aggregate amount of up to $30,000,000 depending on the amount of additional capital raised by Luminar prior to the closing of the Proposed Business Combination, divided by $10.00. Holders of shares of (a) Luminar’s Class A common stock, preferred stock and founders preferred stock will be entitled to receive a number of shares of newly-issued Class A Stock </p> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">equal to the Per Share Company Stock Consideration (as defined in the Merger Agreement) issuable in Class A Stock and (b) Luminar’s Class B common stock will be entitled to receive a number of shares of newly-issued Company Class B common stock equal to the Per Share Company Stock Consideration issuable in Company Class B common stock.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the consideration to be paid at the closing of the Proposed Business Combination, stockholders of Luminar will be entitled to receive an additional number of earn-out shares from the Company, issuable in either Class A Stock or Company Class B common stock as provided in the Merger Agreement, of up to 7.5% of the total outstanding capital stock of the Company as of the closing of the Proposed Business Combination (including shares subject to outstanding Luminar stock options, restricted stock and warrants that will be assumed by the Company in connection with the Proposed Business Combination.</p> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">For further discussion of the Proposed Business Combination and the Merger Agreement, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Recent Developments— Proposed Luminar Technologies, Inc. Business Combination.”</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financing</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon the IPO Closing Date and the sale of the Private Placement Warrants, an aggregate of $400,000,000 was placed in a Trust Account with Continental Stock Transfer &amp; Trust Company acting as trustee (the “Trust Account”).</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Company intends to finance a Business Combination with the net proceeds from its $400,000,000 Public Offering and its sale of $10,000,000 of Private Placement Warrants (see Note 3).     </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Trust Account</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funds held in the Trust Account can be invested only in U.S. government treasury bills with a maturity of one hundred and eighty (180) days or less or in money market funds meeting certain conditions under Rule 2a‑7 under the Investment Company Act of 1940, as amended, that invest only in direct U.S. government obligations. As of September 30, 2020, the Trust Account consisted of money market funds.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to fund regulatory compliance requirements and other costs related thereto (a “Regulatory Withdrawal”), subject to an annual limit of $750,000, for a maximum 24 months and/or additional amounts necessary to pay franchise and income taxes, if any, none of the funds held in trust will be released until the earliest of: (i) the completion of the Business Combination; or (ii) the redemption of any public shares of common stock properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of such public shares of common stock if the Company does not complete the Business Combination within 24 months from the IPO Closing Date; or (iii) the redemption of 100% of the public shares of common stock if the Company is unable to complete a Business Combination within 24 months from the IPO Closing Date, subject to the requirements of law and stock exchange rules.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Business Combination</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating a Business Combination. The Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (less any deferred underwriting commissions and taxes payable on interest income earned) at the time of the Company signing a definitive agreement in connection with the Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As discussed above, the Company entered into a definitive agreement for the Proposed Business Combination and intends to seek stockholder approval of the Proposed Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Proposed Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest income but less taxes payable.<span style="font-family:Calibri;font-size:11pt;"> </span>The Company will complete the Proposed Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Proposed Business Combination. Currently, the Company will not redeem its public shares of common stock in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its public shares of common stock and the related Proposed Business Combination, and instead may search for an alternate Business Combination.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with a Business Combination, the Company may alternatively provide stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest income but less taxes payable. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval, unless a vote is required by law or under NASDAQ rules</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the foregoing redemption provisions, the public shares of common stock will be recorded at the redemption amount and classified as temporary equity, in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 480, “<span style="font-style:italic;">Distinguishing Liabilities from Equity</span>” (“ASC Topic 480”) in subsequent periods.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will have 24 months from the IPO Closing Date to complete the Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares of common stock for a per share pro rata portion of the Trust Account, including interest income, but less taxes payable (less up to $100,000 of such net interest income to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per Unit in the Public Offering.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Sponsor and the Company’s officers and directors have entered into letter agreements with the Company, pursuant to which they waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the Sponsor or any of the Company’s officers, directors or affiliates acquire public shares of common stock, they will be entitled to a pro rata share of the Trust Account in the event the Company does not complete a Business Combination within the required time period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Proposed Business Combination, the Sponsor and the Company’s independent directors (the “Initial Stockholders”) have also entered into a Waiver Agreement pursuant to which they have waived their rights to a conversion price adjustment with respect to any shares of common stock they may hold in </p> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">connection with the consummation of the Proposed Business Combination. Currently, the Sponsor and the Company’s officers and directors own </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of our issued and outstanding shares of common stock, including all of the Founder Shares (as defined below). </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Emerging Growth Company</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.</p>
CY2020Q3 gmhi Number Of Subsidiaries
NumberOfSubsidiaries
2
CY2019Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
400000000
CY2019Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
400000000
gmhi Regulatory Withdrawal Of Interest From Trust Account Annual Limit
RegulatoryWithdrawalOfInterestFromTrustAccountAnnualLimit
750000
gmhi Regulatory Withdrawal Of Interest From Trust Account Maximum Period
RegulatoryWithdrawalOfInterestFromTrustAccountMaximumPeriod
P24M
CY2020Q3 gmhi Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
gmhi Dissolution Expenses Maximum Allowed
DissolutionExpensesMaximumAllowed
100000
us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution as well as the Trust Account, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.</p>
CY2020Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38420462
CY2019Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38713476
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020Q3 gmhi Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
CY2020Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
405725195
CY2020Q3 gmhi Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
CY2020Q3 gmhi Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
gmhi Dissolution Expenses Maximum Allowed
DissolutionExpensesMaximumAllowed
100000
CY2020Q3 gmhi Redemption Rights Or Liquidating Distributions With Respect To Warrants
RedemptionRightsOrLiquidatingDistributionsWithRespectToWarrants
0
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3098900
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1355865
CY2020Q3 gmhi Working Capital
WorkingCapital
-2520566
CY2019Q4 gmhi Working Capital
WorkingCapital
145774
CY2020Q3 gmhi Deferred Underwriting Compensation Liability Noncurrent
DeferredUnderwritingCompensationLiabilityNoncurrent
14000000
gmhi Percentage Of Deferred Underwriting Discount
PercentageOfDeferredUnderwritingDiscount
0.0350
CY2020Q3 gmhi Deferred Underwriting Discount If Business Combination Not Completed
DeferredUnderwritingDiscountIfBusinessCombinationNotCompleted
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2020Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000
CY2020Q3 gmhi Number Of Votes For Each Share
NumberOfVotesForEachShare
1
CY2020Q3 gmhi Common Stock Shares Issued Inclusive Of Shares Subject To Redemption
CommonStockSharesIssuedInclusiveOfSharesSubjectToRedemption
40000000
CY2020Q3 gmhi Common Stock Shares Outstanding Inclusive Of Shares Subject To Redemption
CommonStockSharesOutstandingInclusiveOfSharesSubjectToRedemption
40000000
CY2020Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
38420462
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0

Files In Submission

Name View Source Status
0001564590-20-051947-index-headers.html Edgar Link pending
0001564590-20-051947-index.html Edgar Link pending
0001564590-20-051947.txt Edgar Link pending
0001564590-20-051947-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gmhi-10q_20200930.htm Edgar Link pending
gmhi-10q_20200930_htm.xml Edgar Link completed
gmhi-20200930.xsd Edgar Link pending
gmhi-20200930_cal.xml Edgar Link unprocessable
gmhi-20200930_def.xml Edgar Link unprocessable
gmhi-20200930_lab.xml Edgar Link unprocessable
gmhi-20200930_pre.xml Edgar Link unprocessable
gmhi-ex311_8.htm Edgar Link pending
gmhi-ex312_7.htm Edgar Link pending
gmhi-ex321_9.htm Edgar Link pending
gmhi-ex322_6.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending